Lexeo Therapeutics, Inc (LXEO) insider trading
Every open-market stock purchase and sale by Lexeo Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Louis Edward Tamayo (CFO) and 2 others sold $43.2K in the last 90 days.
- Last insider buy: Paula H Cholmondeley (Insider), $105K, 23 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $752K (17 sales). Last close $2.89 on Oct 22, 2026.
Recent LXEO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 24, 2026 | Richard Nolan Townsend (CEO) | Bought (not open market) | — |
| Sep 24, 2026 | Jose Manuel Otero (COO) | Bought (not open market) | — |
| Sep 24, 2026 | Narinder Pal Bhalla (C-suite exec) | Bought (not open market) | — |
| Sep 24, 2026 | Louis Edward Tamayo (CFO) | Bought (not open market) | — |
| Sep 14, 2026 | Narinder Pal Bhalla (C-suite exec) | Bought (not open market) | $9.7K |
| Sep 14, 2026 | Richard Nolan Townsend (CEO) | Bought (not open market) | $6.1K |
| Sep 14, 2026 | Jose Manuel Otero (COO) | Bought (not open market) | $5.6K |
| Aug 18, 2026 | Louis Edward Tamayo (CFO) | Sold | $20.2K |
| Aug 18, 2026 | Richard Nolan Townsend (CEO) | Sold | $16.6K |
| Aug 18, 2026 | Jose Manuel Otero (COO) | Sold | $6.5K |
| Jul 1, 2026 | Richard Nolan Townsend (CEO) | Sold | $116K |
| Jul 1, 2026 | Narinder Pal Bhalla (C-suite exec) | Sold | $98.6K |
| Jul 1, 2026 | Jose Manuel Otero (COO) | Sold | $20.9K |
| Jul 1, 2026 | Louis Edward Tamayo (CFO) | Sold | $20.8K |
| Jun 29, 2026 | Jose Manuel Otero (COO) | Bought (not open market) | — |
| Jun 29, 2026 | Narinder Pal Bhalla (C-suite exec) | Bought (not open market) | — |
| Jun 29, 2026 | Louis Edward Tamayo (CFO) | Bought (not open market) | — |
| Jun 29, 2026 | Richard Nolan Townsend (CEO) | Bought (not open market) | — |
| Jun 25, 2026 | Steven Altschuler (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Reinaldo M Diaz (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Brenda Cooperstone (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Mette Kirstine Agger (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Tolga Tanguler (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Timothy Van Hauwermeiren (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Paula H Cholmondeley (Insider) | Bought (not open market) | — |
Who's trading LXEO
- Narinder Pal Bhalla, C-suite exec: sold $98.6K (1 sale), last Sep 24, 2026
- Richard Nolan Townsend, CEO: sold $538K (6 sales), last Sep 24, 2026
- Jose Manuel Otero, COO: sold $60K (5 sales), last Sep 24, 2026
- Louis Edward Tamayo, CFO: sold $41K (2 sales), last Sep 24, 2026
- Brenda Cooperstone, Insider: other filings, last Jun 25, 2026
- Timothy Van Hauwermeiren, Insider: other filings, last Jun 25, 2026
- Tolga Tanguler, Insider: other filings, last Jun 25, 2026
- Reinaldo M Diaz, Insider: other filings, last Jun 25, 2026
- Mette Kirstine Agger, Insider: other filings, last Jun 25, 2026
- Steven Altschuler, Insider: other filings, last Jun 25, 2026
- Paula H Cholmondeley, Insider: other filings, last Jun 25, 2026
- Laura Sepp-Lorenzino, Insider: other filings, last Apr 28, 2026
- Eric Adler, C-suite exec: sold $5.7K (1 sale), last Nov 18, 2025
- Jenny Robertson, C-suite exec: sold $5.1K (1 sale), last Nov 18, 2025
- Tai Sandi See, C-suite exec: sold $3.6K (1 sale), last Nov 18, 2025
Get free alerts when an insider at Lexeo Therapeutics, Inc files a new trade →